Loading clinical trials...
Loading clinical trials...
Randomized, Double-blind, Placebo-controlled Multicenter Study Evaluating the Interest of a Long-term (3 Years) Treatment With Peginterferon Alfa-2b and Ribavirin on Liver Fibrosis in Non-responder Chronic Hepatitis C Patients.
Conditions
Interventions
Peginterferon alfa-2b
Ribavirin
+1 more
Locations
45
Belgium
CHU Brugmann
Brussels, Belgium
Hôpital Bracops
Brussels, Belgium
Hôpital Erasme
Brussels, Belgium
Hôpital de Jolimont
La Louvière, Belgium
CHU Sart Tilman
Liège, Belgium
Service d'Hépatogastroentérologie et d'endoscopie digestive - CH du Pays d'Aix
Aix-en-Provence, France
Start Date
May 1, 2006
Primary Completion Date
February 1, 2013
Completion Date
March 1, 2013
Last Updated
September 4, 2014
NCT04429100
NCT06632444
NCT07122700
NCT06098417
NCT05870969
NCT06867731
Lead Sponsor
ANRS, Emerging Infectious Diseases
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions